Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Local Stocks
WallStreetSelect 114
WallStreetSelect 114
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Dermata Therapeutics Inc
(NQ:
DRMA
)
1.690
UNCHANGED
Streaming Delayed Price
Updated: 10:55 AM EDT, Aug 27, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Dermata Therapeutics Inc
< Previous
1
2
3
4
5
6
7
8
9
Next >
Dermata Therapeutics: Q2 Earnings Insights
August 15, 2022
Dermata Therapeutics (NASDAQ:DRMA) reported its Q2 earnings results on Monday, August 15, 2022 at 04:05 PM. Here's what investors need to know about the announcement.
Via
Benzinga
Dermata Therapeutics Provides Corporate Update and Reports Second Quarter 2022 Financial Results
August 15, 2022
Via
ACCESSWIRE
12 Health Care Stocks Moving In Monday's After-Market Session
August 01, 2022
Gainers Conformis (NASDAQ:CFMS) shares moved upwards by 13.2% to $0.29 during Monday's after-market session. The company's market cap stands at $53.5 million.
Via
Benzinga
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
July 27, 2022
Via
Benzinga
12 Health Care Stocks Moving In Tuesday's Intraday Session
July 26, 2022
Via
Benzinga
Why This Biotechnology Surged More Than 60%; Here Are 67 Biggest Movers From Yesterday
July 27, 2022
Gainers Ayala Pharmaceuticals, Inc. (NASDAQ: AYLA) shares surged 94.3% to close at $1.69 on Tuesday after the company filed a request for the withdrawal of the Registration Statement on Form S-1.
Via
Benzinga
12 Health Care Stocks Moving In Thursday's Intraday Session
July 07, 2022
Via
Benzinga
Tesla, Twitter And 76 Biggest Movers From Friday
July 11, 2022
Gainers Seritage Growth Properties (NYSE: SRG) shares surged 80.3% to settle at $10.96 after the company appointed Adam Metz as Chairman. Preliminary proxy materials also indicated the board...
Via
Benzinga
Why Is Akebia Therapeutics Surging By 28%? 48 Stocks Moving In Friday's Mid-Day Session
July 01, 2022
Gainers Quoin Pharmaceuticals, Ltd. (NASDAQ: QNRX) rose 56.1% to $ 0.7029 after dropping 10% on Thursday.
Via
Benzinga
This Low-Float Stock Jumps Around 148%; Here's 64 Biggest Movers From Yesterday
July 08, 2022
Gainers United Maritime Corporation (NASDAQ: USEA) climbed 147.6% to close at $7.08 on Thursday on heavy momentum following the company's recent listing on the Nasdaq Capital Market.
Via
Benzinga
12 Health Care Stocks Moving In Friday's Pre-Market Session
July 01, 2022
Via
Benzinga
Accolade Shares Jump Around 29%, Here's 75 Biggest Movers From Friday
July 05, 2022
Gainers Omeros Corporation (NASDAQ: OMER) jumped 68.7% to close at $4.64. Clovis Oncology, Inc. (NASDAQ: CLVS) gained 58.3% to settle at $2.85 on Friday.
Via
Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday
July 01, 2022
Good morning, trader! It's time for another look at the biggest pre-market stock movers as we dive into the latest news for Friday!
Via
InvestorPlace
Akebia Therapeutics And 20 Stocks Moving Premarket
July 01, 2022
Gainers Quoin Pharmaceuticals, Ltd. (NASDAQ: QNRX) rose 83.2% to $0.8250 in pre-market trading after dropping 10% on Thursday.
Via
Benzinga
Akerna Shares Dip 53%, Here's 78 Biggest Movers From Yesterday
July 01, 2022
Gainers Revelation Biosciences, Inc. (NASDAQ: REVB) surged 77.4% to close at $1.11 on Thursday after jumping 27% on Wednesday. Revelation Biosciences recently announced completion of dosing for Phase...
Via
Benzinga
12 Health Care Stocks Moving In Thursday's After-Market Session
June 30, 2022
Gainers
Via
Benzinga
Why Is NeuroSense Therapeutics Jumping By 45%? 64 Stocks Moving In Thursday's Mid-Day Session
June 30, 2022
Gainers Revelation Biosciences, Inc. (NASDAQ: REVB) jumped 171.3% to $1.70 after jumping 27% on Wednesday. Revelation Biosciences recently announced completion of dosing for Phase 1b CLEAR clinical...
Via
Benzinga
Dermata Announces Final Patient Enrolled in a Phase 2 Trial of DMT310 for the Once-Weekly Treatment of Moderate-to-Severe Rosacea
June 13, 2022
- Topline results expected in the second half of 2022 -
From
Dermata Therapeutics
Via
AccessWire
Dermata to Present at the H.C. Wainwright Global Investment Conference
May 23, 2022
SAN DIEGO, CA / ACCESSWIRE / May 23, 2022 / Dermata Therapeutics, Inc. (NASDAQ:DRMA) ("Dermata" or the "Company"), a clinical-stage biotechnology company focusing on the treatment of medical and...
From
Dermata Therapeutics
Via
AccessWire
Dermata Therapeutics Provides Corporate Update and Reports First Quarter 2022 Financial Results
May 16, 2022
Dermata completes a $5.0 million private placement financing DMT310 Phase 2 rosacea trial topline results expected in H2 2022 SAN DIEGO, CA / ACCESSWIRE / May 16, 2022 / Dermata Therapeutics, Inc....
From
Dermata Therapeutics
Via
AccessWire
Exposures
Product Safety
12 Health Care Stocks Moving In Monday's Pre-Market Session
May 02, 2022
Via
Benzinga
Dermata Therapeutics Announces Closing of $5.0 Million Private Placement Priced At-the-Market Under Nasdaq Rules
April 25, 2022
SAN DIEGO, CA / ACCESSWIRE / April 25, 2022 / Dermata Therapeutics, Inc. ("Dermata," or the "Company") (NASDAQ:DRMA) (NASDAQ:DRMAW), a clinical-stage biotechnology company focusing on the treatment of...
From
Dermata Therapeutics
Via
AccessWire
Dermata Therapeutics Announces $5.0 Million Private Placement Priced At-the-Market Under Nasdaq Rules
April 21, 2022
SAN DIEGO, CA / ACCESSWIRE / April 21, 2022 / Dermata Therapeutics, Inc. ("Dermata," or the "Company") (NASDAQ:DRMA) and (NASDAQ:DRMAW), a clinical-stage biotechnology company focusing on the treatment...
From
Dermata Therapeutics
Via
AccessWire
Dermata Therapeutics Provides Corporate Update and Reports Full Year 2021 Financial Results
March 28, 2022
DMT310 Phase 2 rosacea trial is over two-thirds enrolled with topline results expected in H2 2022 DMT310 Phase 2 psoriasis trial to start H1 2022, with topline results expected in H1 2023 DMT310 Phase...
From
Dermata Therapeutics
Via
AccessWire
Dermata Therapeutics to Participate in the 2022 Maxim Group Virtual Growth Conference
March 24, 2022
SAN DIEGO, CA / ACCESSWIRE / March 24, 2022 / Dermata Therapeutics, Inc. (NASDAQ:DRMA) ("Dermata" or the "Company"), a clinical-stage biotechnology company focusing on the treatment of medical and...
From
Dermata Therapeutics
Via
AccessWire
12 Health Care Stocks Moving In Tuesday's Intraday Session
March 22, 2022
Gainers Palisade Bio (NASDAQ:PALI) shares rose 34.1% to $1.08 during Tuesday's regular session. Trading volume for this security as of 13:31 EST is 52.4 million, which...
Via
Benzinga
42 Stocks Moving in Monday's Pre-Market Session
March 07, 2022
Gainers Nine Energy Service, Inc. (NYSE: NINE) rose 96.7% to $3.54 in pre-market trading after climbing around 43% on Friday. Shares of low-priced energy stocks jumped as...
Via
Benzinga
75 Biggest Movers From Yesterday
March 22, 2022
Gainers NeuroSense Therapeutics Ltd. (NASDAQ: NRSN) shares jumped 299.4% to close at $6.23 on Monday as the company received clearance from the FDA to initiate a pharmacokinetic...
Via
Benzinga
12 Health Care Stocks Moving In Thursday's After-Market Session
February 24, 2022
Gainers Unicycive Therapeutics (NASDAQ:UNCY
Via
Benzinga
12 Health Care Stocks Moving In Friday's Pre-Market Session
February 18, 2022
Gainers Biofrontera (NASDAQ:BFRA) stock moved upwards by 11.8% to $3.49 during Friday's pre-market session. The market value of their outstanding shares is at $98.9...
Via
Benzinga
< Previous
1
2
3
4
5
6
7
8
9
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.